-/-mice compared to WT mice 24 h after HI, accompanied by no significant changes in plasma IL-18 levels. Three hours after HI, NLRP3 expression occurred in astrocytes located in the hippocampus and habenular nucleus of the thalamus. Microglia only showed scarce expression at this time point, but prominent NLRP3 expression 72 h after HI. Conclusion: Astrocytes are early mediators of NLRP3 activity. No early neuroprotective effect of NLRP3 deficiency in neonatal HI brain damage was shown.
Introduction
Birth asphyxia is a major contributor to neonatal morbidity and mortality [1] . A robust inflammatory response follows shortly after hypoxia-ischemia (HI) [2] , potentially providing both neuroprotective and damaging effects [3] [4] [5] . Innate immune responses are activated within minutes after ischemia [6] , resulting in the release of inflammatory cytokines such as interleukin (IL)-1β and IL-18. The NLRP3 inflammasome is the principal activator of IL-1β and IL-18 [7] . Upon NLRP3 stimulation, active caspase-1 is released, cleaving IL-1β and IL-18 from their proforms.
After HI, there is a limited therapeutic window between the primary and secondary energy failure. Even though the members of the IL-1 family are among the best-studied cytokines in relation to human stroke and hypoxic-ischemic encephalopathy, little is known about the early activity within the first 4-6 h [8] . Increased knowledge of the initial proinflammatory phase, before intervention, is therefore crucial in the development of new pharmacological targets.
NLRP3 activation has been reported to mediate injury in various CNS disorders, such as Alzheimer's disease [9] , meningitis [10] and traumatic brain injury [11] . Recently, both amelioration of brain damage 24 h after the insult and no effect of NLRP3 deficiency have been demonstrated in adult murine stroke models [12, 13] , but its involvement and expression after HI brain injury in neonates has not previously been reported [14] . We therefore wanted to: (i) describe the NLRP3 expression at 3, 24 and 72 h after HI and (ii) examine whether deficiency of NLRP3 affects the susceptibility to brain injury in the neonate 24 h after HI.
Methods

Animals
C57Bl/6 mice (WT) were from Jackson Laboratories. NLRP3 -/-mice were provided by K. Fitzgerald (UMass Medical School) and were backcrossed 10 generations onto the C57Bl/6 background [15] . Animals were housed and bred in a heterozygous pattern at 24 ° C on a 12: 12 h light:dark cycle with access to a diet of pellets and water ad libitum.
Induction of Neonatal Hypoxic-Ischemic Injury
Unilateral common carotid artery ligation followed by hypoxia was performed at P9 as previously described [16] . All pups received analgesia with a subcutaneous injection of buprenorphine (0.01 mg/ kg) prior to anesthesia. A total of 100 mice were used. The animals were randomly allocated to the different groups: gene expression (6 HI, 2 sham), brain damage (57 mice, all HI), immunohistochemistry 3 h (21 HI, 3 sham), immunohistochemistry 24 h (4 HI, 1 sham) and immunohistochemistry 72 h (4 HI, 2 sham). Investigators were blinded to the group allocation when doing surgery and outcome evaluation as the animals were bred heterozygously and genotyping was performed after the experiments. Sample size was determined by power analysis (significance level 0.05, power 80%). The experiments were approved by the Norwegian National Animal Research Committee and conform to the European Guidelines for Use of Experimental Animals by FELASA (Federation of European Laboratory Animals Science Association) researchers and ARRIVE guidelines.
Gene Expression Analyses
The subregions of the brain were dissected by first cutting the brain at bregma 1 mm for isolation of the hippocampus, thalamus and cortex. At bregma 0 mm, the subventricular lining was removed before isolating the striatum. Total RNA was isolated and gene expression analyzed and normalized to mRNA levels of GAPDH as previously described [16] . Sequence-specific primers were as previously published [17] .
Protein Analyses (ELISA)
At 24 h after HI the animals were decapitated and blood was aspirated by a syringe with 20 μl of 0.5 M EDTA. It was then centrifuged for 20 min at 3,400 rpm before the plasma was aspirated and stored at -70 ° C. IL-18 was determined using a mouse IL-18 ELISA kit (R&D Systems) as recommended by the manufacturer.
Immunohistochemistry
Brains were collected and processed as previously described [16] . Coronal sections (4 μm) from the level of the striatum and hippocampus were obtained. The primary antibodies and dilutions used were mouse anti-microtubule-associated protein 2 (MAP2) 1: 8,000 (M4403; Sigma), mouse anti-glial fibrillary acidic protein (GFAP) 1: 50 (G3893; Sigma), rabbit anti-NLRP3 1: 50 (HPA012878; Sigma) and rabbit anti-Iba1 1: 1,000 (019-19741; Wako). The secondary antibodies used were Alexa Fluor 488 and Alexa Fluor 594 (Molecular Probes/Invitrogen), both at a dilution of 1: 500. The entire hemisphere from the level of the striatum and hippocampus were analyzed, including the striatum, cortex, hippocampus and thalamus, and a Nikon Eclipse E400 was used for imaging both bright fields and fluorescence with a 40× objective (field size 0.0741 mm 2 ). Quantifications were performed using ImageJ 1.42 software (National Institutes of Health).
Determination of Brain Damage
For the quantification of brain damage 24 h post-HI, 2,3,5-triphenyltetrazolium chloride (TTC) was used. Mice were decapitated, brains rapidly removed, immersed in cold PBS, cut at 1.0-mm intervals using a Young Mouse Brain Slicer (Zivic Instruments) and stained by TTC as previously described [18] . The infarct area was determined by subtracting the undamaged ipsilateral area from the contralateral hemisphere. The relative infarct area was expressed as a percentage of the contralateral hemisphere. Relative volume loss was calculated by adding the relative infarct areas of each section through the brain divided by the total number of sections obtained.
At 3 h post-HI, brain damage was estimated by MAP2 and hematoxylin-eosin (HE) staining. The indirect method to measure the volume of infarction was also used for MAP2-stained sections. HE-stained images were assessed by neuropathological grading from 1-4 based on findings of perivascular edema, vacuolization of neuropils and dark neurons. The assessments were done by an observer blinded to the study groups (E.M.L.).
Statistical Analyses
Data were analyzed using GraphPad Prism 5 (GraphPad, San Diego, Calif., USA). All values are presented as the mean ± SEM. For nonparametric testing the Kruskal-Wallis test was used a priori when more than two groups were compared, while the Mann-Whitney U test was used for the comparison of two groups. Probability values of p < 0.05 (two-sided) were considered statistically significant.
Results
NLRP3 and IL-1β mRNAs Are Upregulated after Neonatal HI
To determine how NLRP3, IL-1β and IL-18 expression were affected by HI in the neonatal brain, we performed real-time RT-PCR on mRNA isolated from five different subregions in the ipsilateral and contralateral hemisphere, which was obtained 24 h after HI in WT mice ( fig. 1 ) . A significant increase in NLRP3 gene expression was seen in the ipsilateral hippocampus (2.6-fold), striatum (2.2-fold) and thalamus (2.3-fold) compared to the contralateral hemisphere ( fig. 1 a) . The mRNA levels of the contralateral hemisphere showed similar levels as sham-operated animals (data not shown). IL-1β gene regulation showed a similar pattern to NLRP3 with a 5.9-fold upregulation in the hippocampus and 4-fold upregulation in the striatum ( fig. 1 b) . IL-18 mRNA expression, however, was not affected by HI in any of the five subregions analyzed ( fig. 1 c) .
Neonatal HI Injury Is Unaffected by NLRP3 Deficiency
We assessed the brain infarction area with TTC staining 24 h after HI. The total infarction volume did not differ significantly between WT (mean 39.9%), heterozygous (mean 37.4%), and NLRP3 -/-(mean 36.0%) animals ( fig. 2 a) and was not affected by gender (data not shown). The brain infarction area was calculated in six consecutive sections and did not differ significantly at any section level between the three groups. Since we aimed to investigate the acute effect of NLRP3 activation, we also assessed the brain damage 3 h after reoxygenation by neuropathological scoring and loss of MAP2 staining of sections from the level of the hippocampus and striatum ( fig. 2 b, c) . Neither showed any significant differences between WT and NLRP3 -/-.
IL-18 Response in Plasma after Neonatal HI
To investigate whether NLRP3 deficiency resulted in any early systemic effects, we examined blood samples from NLRP3 -/-and WT mice 24 h after HI. In plasma, IL-18 was not significantly lower in NLRP3 -/- 
d).
Cell Type-Specific NLRP3 Expression after Neonatal HI 3 h after HI In accordance with the gene expression data, at 3 h after HI, when comparing the ipsilateral hemisphere of HI and sham-treated animals, a statistically significant increase in NLRP3 intensity was found in two specific regions: the dentate gyrus of the hippocampus and the habenular nucleus of the thalamus, as shown in figure 3 . Double labeling immunofluorescence with either NLRP3 antibody and a microglial marker (IbA1) or an astrocytic marker (GFAP) showed that NLRP3 expression was particularly located to astrocytic cells surrounding the subgranular zone of the dentate gyrus and in the habenular nucleus of the thalamus ( fig. 4 a, b) . In contrast, double labeling with NLRP3 and Iba1 showed no NLRP3 expression in microglia with the exception of a few microglia in the hippocampus ( fig. 4 c) .
As the NLRP3 intensity was increased in the ipsilateral dentate gyrus after HI, and colabeling identified the cells as astrocytes, we compared the astrocytosis in this area in WT and NLRP3 -/-; however, there were no significant difference ( fig. 5 ).
24 h after HI At 24 h after HI, in the areas where NLRP3 activation occurred at 3 h after HI, notably in astrocytes in the denate gyrus and habenular nucleus, there were no NLRP3 immunopositive astrocytes. In contrast, the NLRP3 activity identified was dispersed and starting to spread throughout the infarcted area of the hippocampus, thalamus, striatum and cortex. By colabeling, we identified the NLRP3 expression in astrocytes ( fig. 6 a) .
72 h after HI In order to explore whether the astrocytic NLRP3 immunoreactivity would further increase as the repair processes went on, we stained sections from 72 h after HI. A prominent NLRP3 activation was then selectively seen in the periinfarction areas, again identified in astrocytic cells by colabeling, as shown in figure 6 b. Microglial cells at this time point also showed prominent NLRP3 expression ( fig. 6 c) .
Discussion
For the first time, we report that NLRP3 and IL-1β mRNAs are increased in several regions of the brain at 24 h after neonatal HI. Further studies of the time-depen- 217 dent expression of NLRP3 revealed that early NLRP3 expression was mainly localized to astrocytes, while there was only a few microglia with activated morphology that showed early NLRP3 expression. However, we did not find any early neuroprotective effects of NLRP3 depletion assessed at 3 and 24 h after HI, accompanied by no major changes in plasma levels of IL-18.
Inhibition by the IL-1 receptor antagonist (anakinra) is one of a few promising neuroprotective strategies in adult stroke. In a phase 2 trial it was tested as safe and patients with cortical infarcts showed reduced infarct volumes [8] . Similarly, neonatal HI animal models have shown that postnatal administration of the IL-1 receptor antagonist (IL-1ra) exerts neuroprotection [19] . In adult stroke models, IL-1α/IL-1β deficiency provides neuroprotection [20] , but in neonatal HI this was not observed [21] . Deficiency of NLRP3 has previously been reported to ameliorate brain injury in an adult stroke model [12] . However, in line with our findings, Denes et al. [13] did not find any neuroprotection in NLRP3 -/-adult mice using the same model. Conflicting findings between neonatal HI and adult stroke models have also previously been reported for the end products after NLRP3 activation, namely IL-1β [21] and IL-18 [22] . The neuroprotective effects of the IL-1 receptor antagonist with no effect of NLRP3 deficiency may have several explanations. First, IL-1ra may be neuroprotective by targeting the early detrimental inflammatory response, while mice deficient in the generation of IL-1 cytokines will also be restricted from the later inflammatory component necessary for resolving damaged tissue [21] . Second, IL-1ra blocks the action of both IL-1α and IL-1β, while NLRP3 do not seem to play a central role -/-mice subjected to HI. Importantly, both IL-1β and IL-18 may be released in an inflammasome-independent manner [23] during the early phases of inflammation. During the more chronic phases of active inflammation, macrophages/microglia are the main inflammatory cells, and inflammasomes are suggested to be the major source of IL-1β and IL-18. This could provide an explanation for the high plasma levels of IL-18 in NLRP3 -/-animals. Moreover, this interpretation may also point toward a more central role of the NLRP3 inflammasome in the later stages of HI-induced injury, and such experiments will therefore be conducted by our group.
We report early (3 h after HI) NLRP3 expression in astrocytes in the dentate gyrus and habenular nucleus, as well as increased mRNA levels of NLRP3 and IL-1β at 24 h after HI. Similarly, in a study by Hedtjärn et al. [22] , IL-1β immunopositive cells were only found in the habenular nucleus at 8 h after neonatal HI, and thereafter diminished. Costaining identified these cells as microglia, possibly reflecting the 5-hour difference in the time point after reoxygenation. In line with this, Denes et al. [24] demonstrated early IL-1β expression in astrocytes (4 h) in a transient middle cerebral artery occlusion model, while microglia showed no expression at this time point. In their study Hedtjärn et al. [22] also showed a biphasic pattern of IL-1β protein increase, with a peak at 8 h and a second increase beginning from day 3 to 14. The fact that NLRP3-positive astrocytes showed a similar biphasic pattern with an early activity seen at 3 h in the dentate gyrus and habenular nucleus before a second immunopositivity spreading throughout the infarction area at 72 h could indicate that astrocytes, in addition to microglia, mediate NLRP3 effects.
Astrocyte-mediated effects in HI has gained emerging interest, and Thornton et al. [25] demonstrated that IL-1-mediated injury was mediated through astrocytes and was caspase dependent as only cocultures of astrocytes and neurons showed increased damage after IL-1β administration and the pancaspase inhibitor, Boc-Asp-(OMe)-CH(2) F, abolished the effect. Adult GFAP -/-vimentin -/-mice showed larger infarcts after ischemia, implicating a neuroprotective role of reactive gliosis; however, Jarlestedt et al. [26] did not find a difference in infarction volumes between neonatal GFAP -/-vimentin -/-and WT mice after HI. The astrocytes mediating the early NLRP3 activity in neonatal HI might not be the same cells that potentially result in an overstimulated inflammatory response. We are therefore planning further investigations that will include examination of the NLRP3 activity at later time points and the relative role of inflammation in the neonatal versus the adult brain.
In conclusion we found early upregulation of NLRP3 after neonatal HI, expression of NLRP3 in astrocytes and microglia, but no early neuroprotective effect of NLRP3 deficiency.
